Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Abbvie Inc (ABBV)

Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
ABBV
1 Safe-and-Steady Stock on Our Watchlist and 2 We Find Risky StockStory - Mon Jan 19, 10:37PM CST

1 Safe-and-Steady Stock on Our Watchlist and 2 We Find Risky

MCY : 89.32 (-1.94%)
STC : 65.02 (-1.56%)
ABBV : 214.04 (-0.14%)
A concept image showing a red ladder next to stacks of coins by Pla2na via Shutterstock
The 3 Most Reliable Dividend Stocks to Buy for Years to Come Barchart - Mon Jan 19, 6:30PM CST

These three dividend stocks are long-term winners with dependable payouts.

PEP : 147.66 (+0.92%)
ABBV : 214.04 (-0.14%)
O : 61.62 (+0.33%)
MarketBeat.com
3 “Forever Stocks” to Hold When the Market Won’t Sit Still MarketBeat - Mon Jan 19, 9:31AM CST

Chevron, Colgate-Palmolive, and Merck highlight how dividends, durable businesses, and long-term growth drivers can support a buy-and-hold investment strategy

CVX : 165.30 (-0.58%)
MRK : 109.45 (+0.57%)
CL : 85.44 (+1.09%)
ABBV : 214.04 (-0.14%)
MarketBeat.com
AbbVie Call Options Spike 2,599%: Tracking the Big Bet MarketBeat - Fri Jan 16, 5:36PM CST

Large institutional investors are positioning for growth as a leading biopharmaceutical firm enters the obesity market and reaches a federal agreement.

ABBV : 214.04 (-0.14%)
AbbVie Announces Topline Results for Epcoritamab (DuoBody® CD3xCD20) from Phase 3 EPCORE® DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) PR Newswire - Fri Jan 16, 12:43PM CST

NORTH CHICAGO, Ill. , Jan. 16, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced topline results from the Phase 3 EPCORE ® DLBCL-1 trial evaluating epcoritamab, a T-cell engaging bispecific...

ABBV : 214.04 (-0.14%)
AbbVie and Trump Administration Reach Agreement to Improve Access and Affordability for Americans PR Newswire - Mon Jan 12, 5:30PM CST

NORTH CHICAGO, Ill. , Jan. 12, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced a voluntary agreement with the Trump administration to further advance access and affordability for Americans...

ABBV : 214.04 (-0.14%)
AbbVie and RemeGen Announce Exclusive Licensing Agreement to Develop A Novel Bispecific Antibody for Advanced Solid Tumors PR Newswire - Mon Jan 12, 6:30AM CST

-       RC148 is a novel PD-1/VEGF bispecific antibody being evaluated in multiple advanced solid tumors including certain lung cancers

ABBV : 214.04 (-0.14%)
West Signs Agreement to Sell the Manufacturing and Supply Rights for SmartDose® 3.5mL On-Body Delivery System to AbbVie PR Newswire - Mon Jan 12, 5:00AM CST

EXTON, Pa. , Jan. 12, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that the company...

WST : 250.50 (-3.58%)
ABBV : 214.04 (-0.14%)
AbbVie to Acquire Arizona Manufacturing Facility, Further Strengthening Manufacturing Capabilities in the United States PR Newswire - Mon Jan 12, 5:00AM CST

NORTH CHICAGO, Ill. , Jan. 12, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) and West Pharmaceutical Services (NYSE: WST) announced today a definitive agreement for AbbVie to acquire a device manufacturing...

WST : 250.50 (-3.58%)
ABBV : 214.04 (-0.14%)
MarketBeat.com
This ETF Is Proof That the Healthcare Rebound Is Real MarketBeat - Sun Jan 11, 10:03AM CST

Track healthcare’s 2026 setup: GLP-1 drug adoption, a valuation gap vs. tech, and why VHT offers broad exposure with low fees and dividends.

CVS : 80.09 (+1.90%)
VHT : 289.36 (-0.12%)
NVO : 60.68 (-2.65%)
JNJ : 218.21 (-0.21%)
MRK : 109.45 (+0.57%)
HCA : 464.38 (-1.05%)
ABBV : 214.04 (-0.14%)
UNH : 338.43 (+2.24%)
ELV : 367.06 (-2.08%)
PFE : 25.52 (-0.51%)
TSLA : 419.25 (-4.17%)
LLY : 1,041.29 (+0.28%)

Barchart Exclusives

Trump’s Greenland Threats Scaring You Off? Buy This Dividend Stock as a Hedge Barchart - Tue Jan 20, 6:30PM CST
Trump's threats to seize Greenland have led to a selloff in risk assets while precious metals have rallied amid the flight to safe-haven assets. Agnico-Eagle Mines is a good dividend stock to buy amid the geopolitical turmoil. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot